Tom Frinzi

September 30, 2020

Thomas Frinzi is the former Worldwide President, Surgical, Johnson & Johnson Vision business, which includes a broad ophthalmology portfolio across the areas of cataracts and refractive surgery (LASIK). Tom was appointed to his position in February 2017 at the conclusion of Johnson & Johnson’s acquisition of Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott. Mr. Frinzi joined AMO in January 2016 as Senior Vice President of Abbott Laboratories and President, Abbott Medical Optics.

Prior to joining Abbott, Mr. Frinzi held a number of leadership positions in ophthalmology and medical device companies. Most recently, he served as President and CEO of WaveTec Vision, a developer of surgical systems for eye surgery. He also held senior positions in commercial operations, business development, and sales and marketing at Bausch & Lomb Surgical, Refractec and Johnson & Johnson. In recognition of his leadership, expertise and vision in the field, Mr. Frinzi was awarded the 2015 Ophthalmology Innovation Award by the Ophthalmology Innovation Summit. He earned a bachelor’s degree in political science from the University of Tampa.

Tom Frinzi

Recent Articles

Reducing Fungal Risk in Corneal Transplants: Insights from Nicole Fram, M.D.’s Amphotericin B Research

Reshaping the Future of Keratoconus Care: Dr. Rahul Tonk on CTAK at AAO 2025

Why Surgeons Are Switching to the I-II Marking for DMEK and DSEK

Growing for Greater Impact: CorneaGen Expands in Orlando to Better Serve Surgeons and Patients